Related Experiment Video

Updated: Dec 31, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.7K

Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth

Cecilia Dyberg1, Teodora Andonova1, Thale Kristin Olsen1

  • 1Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.

Cancers
|January 1, 2020
PubMed

Insights

Rho-associated kinases (ROCKs) are crucial in medulloblastoma, a common childhood brain cancer. Inhibiting ROCKs with RKI-1447 suppressed tumor growth and metastasis, offering a potential new therapy for aggressive cases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Medulloblastoma is a frequent pediatric brain tumor with a 70% survival rate.
  • Metastatic and relapsed tumors significantly increase mortality.
  • Rho-associated kinases (ROCKs) are implicated in epithelial-mesenchymal transition (EMT) and cancer metastasis.

Purpose of the Study:

  • To investigate the role of ROCKs in medulloblastoma.
  • To evaluate the efficacy of ROCK inhibitors as a potential therapeutic strategy for medulloblastoma, particularly metastatic forms.

Main Methods:

  • Assessed ROCK expression in medulloblastoma samples.
  • Tested three ROCK inhibitors on medulloblastoma cell lines.
  • Utilized differential gene expression analysis to identify affected pathways.
  • Evaluated the in vivo efficacy of RKI-1447 in a medulloblastoma model.

Main Results:

  • ROCKs are expressed in medulloblastoma, with higher ROCK2 mRNA in metastatic tumors.
  • Medulloblastoma cell lines showed sensitivity to pharmacological ROCK inhibition.
  • RKI-1447 inhibited medulloblastoma cell tumorigenicity, migration, and invasion.
  • ROCK inhibition downregulated proliferation and metastasis-associated pathways (e.g., TNFα, TGFβ, EMT) and key proteins (RHOA, RHOB, JUN, vimentin).
  • RKI-1447 suppressed medulloblastoma growth and proliferation in vivo.

Conclusions:

  • ROCK inhibition is a promising therapeutic strategy for medulloblastoma.
  • This approach may be particularly beneficial for patients with metastatic disease.
  • Targeting ROCKs could offer a novel treatment option for pediatric medulloblastoma.
Keywords:
ROCKROCK inhibitorRhoRho-associated kinaseepithelial-mesenchymal transitionmedulloblastomametastasis

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.5K
Inducible and Reversible Dominant-negative DN Protein Inhibition08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.7K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K